Vol 14, No 3 (2018)
Case report
Published online: 2018-06-21

open access

Page views 451
Article views/downloads 549
Get Citation

Connect on Social Media

Connect on Social Media

A case of B-cell lymphoma of the uterus

Olivia Jakubowicz1, Dominika Hempel2, Marek Z. Wojtukiewicz2, Ewa Sierko2
DOI: 10.5603/OCP.2018.0022
Oncol Clin Pract 2018;14(3):164-166.

Abstract

Primary malignant lymphoma occurs rarely in the female reproductive tract. A case of a 64-year-old female patient diagnosed with B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma (B-UCL) of the uterus is presented. The patient underwent three cycles of chemotherapy based on R-CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with rituximab), radiation therapy to the pelvis, and extended hysterectomy. The follow-up has been conducted for three years. No sign of disease recurrence has been observed in physical examination and on images.

Article available in PDF format

View PDF Download PDF file

References

  1. Vang R, Medeiros LJ, Ha CS, et al. Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases. Mod Pathol. 2000; 13(1): 19–28.
  2. Okuda T, Ijichil S, Yamashita S, et al. Diagnostic usefulness of FDG-PET/CT in advanced malignant lymphoma of the uterus: report of two cases. Eur J Gynaecol Oncol. 2015; 36(6): 737–741.
  3. Mandato VD, Palermo R, Falbo A, et al. Primary diffuse large B-cell lymphoma of the uterus: case report and review. Anticancer Res. 2014; 34(8): 4377–4390.
  4. Samama M, van Poelgeest M. Primary malignant lymphoma of the uterus: a case report and review of the literature. Case Rep Oncol. 2011; 4(3): 560–563.
  5. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127(20): 2375–2390.
  6. Stroh EL, Besa PC, Cox JD, et al. Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy. Cancer. 1995; 75(9): 2392–2399, doi: 10.1002/1097-0142(19950501)75:9<2392::aid-cncr2820750932>3.0.co;2-y.
  7. Cubo AM, Soto ZM, Cruz MÁ, et al. Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report. Medicine (Baltimore). 2017; 96(19): e6846.
  8. Hashimoto A, Fujimi A, Kanisawa Y, et al. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report]. Gan To Kagaku Ryoho. 2013; 40(13): 2589–2592.
  9. Sharma V, Dora T, Patel M, et al. Case Report of Diffuse Large B Cell Lymphoma of Uterine Cervix Treated at a Semiurban Cancer Centre in North India. Case Rep Hematol. 2016; 2016: 3042531.
  10. Perry AM, Crockett D, Dave BJ, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases. Br J Haematol. 2013; 162(1): 40–49.
  11. Zhao L, Ma Q, Wang Q, et al. Primary diffuse large B cell lymphoma arising from a leiomyoma of the uterine corpus. Diagn Pathol. 2016; 11: 9.
  12. Bürgesser MV, Gualco G, Diller A, et al. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina. Ann Diagn Pathol. 2013; 17(3): 250–255.
  13. Baryakh EA, Misyurina AE, Kovrigina AM, et al. [Diagnosis and treatment in patients with B-cell lymphoma unclassified that is intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma]. Ter Arkh. 2015; 87(8): 77–85.
  14. Yahalom J, Illidge T, Specht L, et al. International Lymphoma Radiation Oncology Group. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015; 92(1): 11–31.